Clinical Trial Update: Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

View source ↗

Summary

A clinical trial update evaluating whether gonadotropin-releasing hormone agonists can preserve ovarian function in women with systemic lupus erythematosus who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Insufficiency
• Systemic Lupus Erythematosus

Drugs mentioned

• Gonadotropin-releasing hormone agonist (GnRHa) (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Systemic Lupus Erythematosus (Sle), Primary Ovarian Insufficiency (Poi) | Status: RECRUITING